| Literature DB >> 35210806 |
Abstract
BACKGROUND: Telomere maintenance is increasingly being considered as fundamental to the progression of immune-mediated inflammatory diseases. However, the causality underlying the purported relationship has not been fully elucidated. In the present work, we applied Mendelian randomization (MR) analysis to obtain estimates of the causal effect of telomere length (TL) on the risk of juvenile idiopathic arthritis (JIA) and JIA-associated iridocyclitis.Entities:
Keywords: JIA-associated iridocyclitis; Mendelian randomization; genetics; juvenile idiopathic arthritis; telomere length
Year: 2022 PMID: 35210806 PMCID: PMC8857969 DOI: 10.2147/JIR.S354619
Source DB: PubMed Journal: J Inflamm Res ISSN: 1178-7031
Figure 1Mendelian randomization model of leukocyte TL and risk of JIA and JIA-associated iridocyclitis. The study design is under the assumption that genetic variants are directly associated with TL, but not indirectly with TL and not directly with confounders, that is, the instrumental variables influence JIA and JIA-associated iridocyclitis only directly through TL.
Characteristics of SNPs Selected as the IV and Association with Leukocyte TL
| No. | SNP | Chr. | Position | Proximal | EA | OA | EAF | Beta | SE | Remove | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | rs2695242 | 1 | 226,594,038 | PARP1 | C | A | 0.830 | 0.042 | 0.006 | 9.6E-11 | 0.0021 | 41.9610 | |
| proxy of rs3219104 (r2=1) | |||||||||||||
| 2 | rs10936600 | 3 | 169,514,585 | TERC | T | A | 0.243 | −0.086 | 0.006 | 7.18E-51 | 0.0019 | 225.2677 | Palindromic |
| 3 | rs4683917 | 3 | 101,186,025 | SENP7 | A | C | 0.579 | −0.037 | 0.007 | 2.45E-08 | 0.0030 | 31.1529 | |
| proxy of rs55749605 (r2=1) | |||||||||||||
| 4 | rs13137667 | 4 | 71,774,347 | MOB1B | C | T | 0.959 | 0.077 | 0.014 | 2.43E-08 | 0.0011 | 31.1630 | |
| 5 | rs4691895 | 4 | 164,048,199 | NAF1 | C | G | 0.783 | 0.058 | 0.006 | 1.58E-21 | 0.0024 | 90.9546 | Palindromic |
| 6 | rs7705526 | 5 | 1,285,974 | TERT | A | C | 0.328 | 0.082 | 0.006 | 5.34E-45 | 0.0026 | 198.3350 | |
| 7 | rs2853677 | 5 | 1,287,194 | TERT | A | G | 0.592 | −0.064 | 0.005 | 3.35E-31 | 0.0021 | 135.1105 | |
| 8 | rs2736176 | 6 | 31,587,561 | PRRC2A | C | G | 0.313 | 0.034 | 0.005 | 3.53E-10 | 0.0026 | 39.4232 | Palindromic |
| 9 | rs34991172 | 6 | 25,480,328 | CARMIL1 | G | T | 0.068 | −0.061 | 0.010 | 6.19E-09 | 0.0011 | 33.8236 | |
| 10 | rs59294613 | 7 | 124,554,267 | POT1 | A | C | 0.293 | −0.041 | 0.005 | 1.17E-13 | 0.0021 | 55.1500 | |
| 11 | rs9419958 | 10 | 105,675,946 | STN1(OBFC1) | C | T | 0.862 | −0.064 | 0.007 | 5.05E-19 | 0.0016 | 79.5213 | |
| 12 | rs228595 | 11 | 108,105,593 | ATM | A | G | 0.417 | −0.028 | 0.005 | 1.43E-08 | 0.0024 | 32.1985 | |
| 13 | rs2302588 | 14 | 73,404,752 | DCAF4 | C | G | 0.100 | 0.048 | 0.008 | 1.68E-08 | 0.0017 | 31.8763 | Palindromic |
| 14 | rs3785074 | 16 | 69,406,986 | TERF2 | G | A | 0.263 | 0.035 | 0.006 | 4.64E-10 | 0.0024 | 38.8811 | |
| 15 | rs62053580 | 16 | 74,680,074 | RFWD3 | G | A | 0.169 | −0.039 | 0.007 | 4.06E-08 | 0.0017 | 30.1692 | |
| 16 | rs7194734 | 16 | 82,199,980 | MPHOSPH6 | T | C | 0.782 | −0.037 | 0.006 | 6.94E-10 | 0.0020 | 38.0989 | |
| 17 | rs8105767 | 19 | 22,215,441 | ZNF208 | G | A | 0.289 | 0.039 | 0.005 | 5.42E-13 | 0.0025 | 52.1238 | |
| 18 | rs75691080 | 20 | 62,269,750 | RTEL1/STMN3 | T | C | 0.091 | −0.067 | 0.009 | 5.99E-14 | 0.0013 | 56.4560 | |
| 19 | rs73624724 | 20 | 62,436,398 | RTEL1/ZBTB46 | C | T | 0.129 | 0.051 | 0.007 | 6.33E-12 | 0.0019 | 47.3029 | |
| 20 | rs34978822 | 20 | 62,291,599 | RTEL1 | G | C | 0.015 | −0.140 | 0.023 | 7.26E-10 | 0.0004 | 38.0094 | Palindromic |
Abbreviations: SNP, single-nucleotide polymorphism; IV, instrumental variable; TL, telomere length; EA, effect allele; OA, other allele; EAF, effect allele frequency; SE, standard error.
MR Results of the Association Between Leukocyte TL and the Risk of JIA
| N | OR (95% CI) | N | OR (95% CI) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Full Set | Proxy SNPs Not Identified in Outcome | |||||||||||
| IVW | 13 | 1.68 (1.13–2.48) | 0.009 | 0.577 | – | – | 15 | 1.59 (1.09–2.30) | 0.015 | 0.664 | – | |
| Maximum likelihood | 13 | 1.69 (1.14–2.51) | 0.008 | 0.583 | – | – | 15 | 1.60 (1.10–2.32) | 0.014 | 0.669 | – | – |
| MR-PRESSO | 13 | 1.68 (1.16–2.41) | 0.017 | – | – | 0.549 | 15 | 1.59 (1.14–2.21) | 0.017 | – | – | 0.648 |
| MR-RAPS | 13 | 1.69 (1.13–2.51) | 0.010 | – | – | – | 15 | 1.59 (1.09–2.33) | 0.016 | – | – | – |
| MR-Egger intercept | 13 | – | – | – | 0.175 | – | 15 | – | – | – | 0.314 | – |
Abbreviations: MR, Mendelian randomization; TL, telomere length; JIA, juvenile idiopathic arthritis; N, number of SNPs used in MR analysis; OR, odds ratio; CI, confidence interval; IVW, inverse variance weighted; PRESSO, pleiotropy residual sum and outlier; RAPS, robust adjusted profile score.
Figure 2Scatter plot of the effect size and 95% CIs of each SNP on leukocyte TL and JIA risk. The horizontal axis represents genetic associations of each variant on leukocyte TL. The vertical axis indicates the genetic association of each SNP with risk of JIA.
Abbreviations: SNP, single-nucleotide polymorphism; TL, telomere length; JIA, juvenile idiopathic arthritis.
Figure 3Radial plots to visualize individual outlier SNPs in the MR estimates for the effect of leukocyte TL and risk of JIA. The radial curve displays the ratio estimate for each SNP, as well as the overall IVW estimate (in blue). Black dots show valid SNPs.